Low dose streptozotocin causes stimulation of the immune system and of anti-islet cytotoxicity in mice
Open Access
- 1 November 1991
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 86 (2), 266-270
- https://doi.org/10.1111/j.1365-2249.1991.tb05808.x
Abstract
Multiple low doses of streptozotocin arc known to induce immune-mediated insulin deficient diabetes and depression of immune reactivity. We show here that immune depression by streptozotocin is not general but that some parts of the immune system are stimulated. Spleen cells from streptozotocin-treated mice showed enhanced cytotoxicity against syngeneic islet cells and various tumour cells including insulinoma cells. Several cell types served as effector cells, including macrophages, asialo GM1+ and Lyt-2+ lymphocytes. The increased cytotoxic activity towards islet cells was mostly due to macrophages and to non-asialo GM1+ and non-Lyt-2+ lymphocytes. A higher activation state of macrophages in low dose streptozotocin-treated mice was demonstrated by measurements of superoxide anion release. We conclude that multiple low doses of streptozotocin stimulate ‘natural cytotoxicity’, i.e. the non-MHC restricted cytotoxic activity of macrophages, T cells and natural killer lymphocytes.Keywords
This publication has 22 references indexed in Scilit:
- Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma.The Journal of Immunology, 1989
- L3T4 AN LYT-2 T-CELLS ARE BOTH INVOLVED IN THE GENERATION OF LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE1987
- Mouse models of insulin dependent diabetes: Low‐dose streptozocin‐induced diabetes and nonobese diabetic (NOD) miceDiabetes/Metabolism Research and Reviews, 1987
- Multiple low-dose streptozotocin-induced diabetes in the mouse: further evidence for involvement of an anti-B cell cytotoxic cellular auto-immune responseDiabetologia, 1987
- Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in miceImmunology Letters, 1986
- Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic miceDiabetologia, 1985
- Immune responses of diabetic animalsDiabetologia, 1979
- Complete protection from low-dose streptozotocin-induced diabetes in miceNature, 1978
- Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes MellitusScience, 1976
- Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection.Journal of Clinical Investigation, 1976